Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H16ClF2N9O |
| Molecular Weight | 507.883 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(F)=C(C=C1)C2=NC([C@H]3CCC4=CC(=CC(=O)N34)C5=CC(Cl)=CC=C5N6C=NN=N6)=C(F)N2
InChI
InChIKey=YVACZLFZCFGMPP-QGZVFWFLSA-N
InChI=1S/C23H16ClF2N9O/c24-12-1-4-16(34-10-28-32-33-34)15(9-12)11-7-13-2-5-17(35(13)19(36)8-11)20-22(26)31-23(30-20)14-3-6-18(27)29-21(14)25/h1,3-4,6-10,17H,2,5H2,(H2,27,29)(H,30,31)/t17-/m1/s1
| Molecular Formula | C23H16ClF2N9O |
| Molecular Weight | 507.883 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 21:25:57 GMT 2025
by
admin
on
Wed Apr 02 21:25:57 GMT 2025
|
| Record UNII |
M2V3YU3DSM
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000044084
Created by
admin on Wed Apr 02 21:25:57 GMT 2025 , Edited by admin on Wed Apr 02 21:25:57 GMT 2025
|
PRIMARY | |||
|
M2V3YU3DSM
Created by
admin on Wed Apr 02 21:25:57 GMT 2025 , Edited by admin on Wed Apr 02 21:25:57 GMT 2025
|
PRIMARY | |||
|
121404901
Created by
admin on Wed Apr 02 21:25:57 GMT 2025 , Edited by admin on Wed Apr 02 21:25:57 GMT 2025
|
PRIMARY | |||
|
1941243-22-6
Created by
admin on Wed Apr 02 21:25:57 GMT 2025 , Edited by admin on Wed Apr 02 21:25:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
OFF-TARGET->INHIBITOR |
Ki
|
||
|
TARGET -> INHIBITOR |
COMPETITIVE INHIBITOR
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Biological Half-life | PHARMACOKINETIC |
|
|
|||